- Facing pharmacy trends for the remainder of the year
- Senate passes Drug Quality and Security Act
- Kathleen Sebelius cites pharmacists' importance as Rite Aid CEO introduces Obamacare resource program
- On the heels of Q3, Walgreens outlines shift in front-end strategy and pharmacy tailwinds looking forward
- NACDS, NCPA, GPhA express support for Drug Quality and Security Act
THOUSAND OAKS, Calif. Biotech company Amgen took home a top award for one of its drugs at an annual event for drug makers, the company said Friday.
Amgen won the Best New Drug award for the osteoporosis treatment Prolia (denosumab) at the 2010 Scrip Awards in London Thursday.
The drug works by targeting the cells that break down bone, called osteoclasts, and was named one of the top 10 medical breakthroughs of 2009 in Time magazine.